Skip to main content

Table 1 Patient characteristics

From: Is in vivo and ex vivo irradiation equally reliable for individual Radiosensitivity testing by three colour fluorescence in situ hybridization?

Lung cancer

Rectal cancer

n

43

274

Gender (%) *

 Male

34 (79)

76 (28)

 Female

9 (21)

198 (72)

Age (years)

 Mean age

65.2

63.4

 Range

49–83

23–87

Chemotherapy (agent)

 5-FU

 

52

 5-FU/Platin-derivative

4

189

 Cisplatin in combination with other agents

17

 

 Carboplatin (solo or in combination)

14

 

 Other Chemotherapy

5

20

 No Chemotherapy

3

13

Staging

 I

1

3

 II

4

30

 III

18

176

 IV

11

37

 unknown

9

28